Breaking News

Stevanato Group Secures $235.4 Million in Financing

Will support its ongoing capital expenditure projects in Italy and the U.S.

Author Image

By: Charlie Sternberg

Associate Editor

Stevanato Group S.p.A., a global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, has secured €200 million ($235.4 million) in financing through agreements with BNL BNP Paribas, Cassa Depositi e Prestiti (CDP), and Banco BPM, intended to support its ongoing capital expenditure projects in Cisterna di Latina (Italy) and Fishers (Indiana, U.S.). The financing agreements bolster Stevanato Group’s capac...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters